There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific Corp (NYSE:BSX) and BioNano Genomics Inc (NASDAQ:BNGO) with bullish sentiments.
Boston Scientific Corp (BSX)
BTIG analyst Sean Lavin reiterated a Buy rating on Boston Scientific Corp yesterday and set a price target of $37. The company’s shares opened today at $38.29, close to its 52-week high of $38.49.
According to TipRanks.com, Lavin is a 5-star analyst with an average return of 14.8% and a 63.4% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings Inc, Helius Medical Technologies, and Tactile Systems Technology.
Currently, the analyst consensus on Boston Scientific Corp is a Strong Buy with an average price target of $39.80, implying a 3.9% upside from current levels. In a report issued on September 10, Needham also maintained a Buy rating on the stock with a $43 price target.
.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
